One thing I just noticed different with the ODD st
Post# of 148177
(Total Views: 255)
Posted On: 05/08/2019 1:59:17 PM
One thing I just noticed different with the ODD statements between the 20 Feb and today's PR is the initial one in Feb stated TNBC where today's said mTNBC. I wonder if this addition of metastatic means the previous request needed resubmitted?
Seems minor, especially since 95% of TNBC is metastatic, but may be important as they are pursuing MOA for all metastatic cancers and this may be required to distinguish the other 5% or the FDA is requiring for ODD approval?
Additionally, it would be nice if they would some of those creative and catchy terms like 'functional cure' to the HIV mono and/or cancer PRs (if/once clinical results are available).
Seems minor, especially since 95% of TNBC is metastatic, but may be important as they are pursuing MOA for all metastatic cancers and this may be required to distinguish the other 5% or the FDA is requiring for ODD approval?
Additionally, it would be nice if they would some of those creative and catchy terms like 'functional cure' to the HIV mono and/or cancer PRs (if/once clinical results are available).
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼